SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-043723
Filing Date
2020-02-21
Accepted
2020-02-20 17:35:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d886213dsc13da.htm SC 13D/A 33800
  Complete submission text file 0001193125-20-043723.txt   35174
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88731 | Film No.: 20636521
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2450 HOLCOME BLVD. SUITE J-608 HOUSTON TX 77021
Business Address
Northrup Jonathan P (Filed by) CIK: 0001770559 (see all company filings)

Type: SC 13D/A